Louis C. Lucido - Dec 30, 2022 Form 4 Insider Report for BioCorRx Inc. (BICX)

Role
Director, 10%+ Owner
Signature
/s/ Louis C. Lucido
Stock symbol
BICX
Transactions as of
Dec 30, 2022
Transactions value $
$2,513
Form type
4
Date filed
1/4/2023, 03:16 PM
Previous filing
Dec 15, 2022
Next filing
Jan 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BICX Common Stock, par value $0.001 Purchase $195 +200 +0.22% $0.98 89.6K Dec 30, 2022 Direct
transaction BICX Common Stock, par value $0.001 Purchase $118 +115 +0.13% $1.03 89.7K Dec 30, 2022 Direct
transaction BICX Common Stock, par value $0.001 Award $0 +5.32K +5.93% $0.00 95.1K Dec 30, 2022 Direct F1
transaction BICX Common Stock, par value $0.001 Purchase $2.2K +2K +2.1% $1.10 97.1K Jan 3, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.94